Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Some patients with low-grade Ta nonmuscle-invasive bladder cancer (LG Ta NMIBC) can experience recurrence after many years.

A recent study finds that sequential gemcitabine/docetaxel treatment offers better outcomes than additional BCG therapy for ...

A woman undergoing treatment for cancer took a dip in the Ganga river on Monday, hoping the auspicious occasion of Mauni Amavasya turns the tides for her and helps her battle the disease. Nirmala came ...

N1 Single lymph node metastasis, 2 cm or less in greatest ... The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

Pfizer’s GU portfolio includes seven approved medicines across bladder ... in patients with metastatic castration-resistant prostate cancer (mCRPC), which will be featured in ASCO GU’s ...

A woman undergoing treatment for cancer took a dip in the Ganga river, hoping the auspicious occasion of Mauni Amavasya turns ...

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

Radical cystectomy for invasive bladder cancer remains the standard of care ... The apparent antitumor activity of systemic chemotherapy in the metastatic setting [3] has led to the exploration ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).